Arkolith/Insider Trading/BDSX/Form 4

Hutton Scott

President & CEO, DirectorBIODESIX INC (BDSX) · full profile →Form 4 · filed Feb 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$36K
Net Open-Market Flow
-$36K
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 10, 2026Sell(S)4K$10.08$36K45K
Feb 9, 2026Option exercise(M)10K——49K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2026Option exercise(M)610—$00
Feb 9, 2026Option exercise(M)9K—$09K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-000633) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML